Your browser doesn't support javascript.
loading
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).
Patel, Jai N; Jiang, Chen; Owzar, Kouros; Mulkey, Flora; Luzum, Jasmine A; Mamon, Harvey J; Haller, Daniel G; Dragovich, Tomislav; Alberts, Steven R; Bjarnason, Georg; Willet, Christopher G; Niedzwiecki, Donna; Enzinger, Peter; Ratain, Mark J; Fuchs, Charles; McLeod, Howard L.
Afiliación
  • Patel JN; Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte.
  • Jiang C; Alliance Statistics and Data Center.
  • Owzar K; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
  • Mulkey F; Alliance Statistics and Data Center.
  • Luzum JA; Department of Clinical Pharmacy, University of Michigan, Ann Arbor, Michigan.
  • Mamon HJ; Department of Radiation Oncology, Dana-Farber/Partners CancerCare, Boston, Massachusetts.
  • Haller DG; Department of Gastrointestinal Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Dragovich T; Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, Arizona.
  • Alberts SR; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bjarnason G; Department of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Willet CG; Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina.
  • Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
  • Enzinger P; Department of Radiation Oncology, Dana-Farber/Partners CancerCare, Boston, Massachusetts.
  • Ratain MJ; Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois.
  • Fuchs C; Department of Medical Oncology, Smilow Cancer Hospital, Yale University, New Haven, Connecticut.
  • McLeod HL; Department of Precision Medicine, USF Taneja College of Pharmacy and the Geriatric Oncology Consortium, Tampa, Florida, USA.
Pharmacogenet Genomics ; 31(9): 215-220, 2021 12 01.
Article en En | MEDLINE | ID: mdl-34149004
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Cisplatino Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Pharmacogenet Genomics Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Cisplatino Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Pharmacogenet Genomics Año: 2021 Tipo del documento: Article